Literature DB >> 25925697

Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.

Xiaomei Li1, Bei Xu2, Yan Ma1, Xiangpei Li1, Qi Cheng3, Ximei Wang1, Guosheng Wang1, Long Qian1, Li Wei4.   

Abstract

AIM: To assess the clinical and laboratory features of primary Sjogren's syndrome (pSS) in a large teaching hospital in China.
METHODS: Three hundred and fifteen pSS patients diagnosed according to American-European Classification Criteria and consecutively admitted to Anhui Provincial Hospital from 1 January 1999 to 30 September 2012 were retrospectively selected in this study.
RESULTS: The median age was 46.8 ± 14.4 years (range 13-83 years) and the majority of patients were female (96.5%). The common clinical features at initial presentations were dry mouth (50.2%), dry eyes (31.4%) and joint pain (24.8%); 92.6% of patients had positive anti-SSA antibody and 49.2% patients had positive anti-SSB antibody. One hundred and eighteen patients underwent labial salivary gland biopsy. According to Chisholm grading criteria, grade 3 to 4 was present in 58.5% of the patients. The frequency of interstitial lung disease (ILD) occurred (20.9%) in the patients with systemic extraglandular manifestations. The patients with ILD were frequently associated with positive anti-SSA (P = 0.005) and low levels of C3. The most common impairment of lung function was small airway function abnormalities. Sixty-six pSS patients with ILD (pSS-ILD) were diagnosed with high-resolution computed tomography and treated with corticosteroids and/or immunosuppressants, in which 18 patients had improved pulmonary function.
CONCLUSION: Labial salivary gland biopsy and anti-nuclear antibodies spectrum were important to the diagnosis of pSS. The pSS patients had high percentage of ILD, especially small airway function abnormalities. The combination of corticosteroids and immunosuppressants appears to be effective in treatment of pSS patients with ILD.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  complications; primary Sjogren's syndrome; retrospective analysis

Mesh:

Substances:

Year:  2015        PMID: 25925697     DOI: 10.1111/1756-185X.12583

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  11 in total

1.  Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjögren syndrome.

Authors:  Zhenyu Li; Ting Fu; Lin Li; Yafei Cui; Chen Dong; Jing Li; Zhifeng Gu
Journal:  Clin Rheumatol       Date:  2018-08-09       Impact factor: 2.980

2.  KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case-Control Study.

Authors:  Yu-Hsiang Chiu; Chen-Chih Chu; Chun-Chi Lu; Feng-Cheng Liu; Shin-En Tang; Shi-Jye Chu; San-Yuan Kuo; Hsiang-Cheng Chen
Journal:  J Inflamm Res       Date:  2022-04-08

3.  Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.

Authors:  Shi-Hao He; Yu-Jie He; Kuang-Jin Guo; Xu Liang; Shan-Shan Li; Tian-Fang Li
Journal:  Clin Rheumatol       Date:  2021-11-10       Impact factor: 2.980

4.  Serum-negative Sjogren's syndrome with minimal lesion nephropathy as the initial presentation: A case report.

Authors:  Chun-Yan Li; Yi-Man Li; Mei Tian
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

5.  Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.

Authors:  Jennifer Lee; Jung Hee Koh; Ji-Won Kim; Yoon-Kyoung Sung; Shin-Seok Lee; Jung Yoon Choe; Seung-Cheol Shim; Hyun-Sook Kim; Hae-Rim Kim; Ji-Min Kim; Sung Ryul Kwon; Hyun-Ok Kim; Kichul Shin; Chang Hoon Lee; So-Hyang Chung; Seung-Ki Kwok; Ji Hyeon Ju; Sung-Hwan Park
Journal:  Rheumatol Int       Date:  2018-07-20       Impact factor: 2.631

6.  A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.

Authors:  Xin Dong; Junfei Zhou; Xiaojuan Guo; Yifan Li; Yuetong Xu; Qiang Fu; Yong Lu; Yi Zheng
Journal:  Clin Rheumatol       Date:  2018-09-22       Impact factor: 2.980

7.  Risk factors for primary Sjögren syndrome-associated interstitial lung disease.

Authors:  Yong Wang; Ziliang Hou; Meihua Qiu; Qiao Ye
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

8.  CXCR2 May Serve as a Useful Index of Disease Activity in Interstitial Lung Disease Associated With Primary Sjögren's Syndrome.

Authors:  Xiaofang Zhu; Saisai Lu; Lixia Zhu; Mengjiao Yu; Tingting Wei; Xiaochun Zhu; Dan Chen; Chengshui Chen
Journal:  Front Mol Biosci       Date:  2021-05-13

Review 9.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

10.  LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients.

Authors:  Tsutomu Tanaka; Blake M Warner; Toshio Odani; Youngmi Ji; Ying-Qian Mo; Hiroyuki Nakamura; Shyh-Ing Jang; Hongen Yin; Drew G Michael; Noriyuki Hirata; Futoshi Suizu; Satoko Ishigaki; Fabiola Reis Oliveira; Ana Carolina F Motta; Alfredo Ribeiro-Silva; Eduardo M Rocha; Tatsuya Atsumi; Masayuki Noguchi; John A Chiorini
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.